Clinical Trials Browser

Pancreatic Ductal Adenocarcinoma (PDAC) × Gemcitabine × Gastrointestinal × Clear all

NCT06182072 2025-10-01

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)